Abnormal corpus callosum morphology
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of skull size
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Heterozygous Variants in KMT2E Cause a Spectrum of Neurodevelopmental Disorders and Epilepsy.
|
31079897 |
2019 |
Adenocarcinoma
|
0.010 |
AlteredExpression
|
group |
BEFREE |
In addition, upregulation of MLL5 expression was correlated with increased expression of OGT and USP7 in human primary cervical adenocarcinomas.
|
26678539 |
2015 |
Aggressive behavior
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Anxiety
|
0.100 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Anxiety
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Arteriosclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
In early lesions, PPARG was identified as a specific master regulator of the PCL-responsive atherosclerosis TF-regulatory network, whereas in mature and advanced lesions, the specific master regulators were MLL5 and SRSF10/XRN2, respectively.
|
24586211 |
2014 |
Atherosclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
In early lesions, PPARG was identified as a specific master regulator of the PCL-responsive atherosclerosis TF-regulatory network, whereas in mature and advanced lesions, the specific master regulators were MLL5 and SRSF10/XRN2, respectively.
|
24586211 |
2014 |
Autistic Disorder
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Heterozygous Variants in KMT2E Cause a Spectrum of Neurodevelopmental Disorders and Epilepsy.
|
31079897 |
2019 |
Cerebral cortical atrophy
|
0.100 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
cervical cancer
|
0.010 |
Biomarker
|
disease |
BEFREE |
A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers.
|
21908553 |
2011 |
Child Development Disorders, Pervasive
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Identification of common genetic risk variants for autism spectrum disorder.
|
30804558 |
2019 |
Congenital chromosomal disease
|
0.010 |
GeneticVariation
|
group |
BEFREE |
MLL5 is a mammalian trithorax group (trx-G) gene identified within chromosome band 7q22, a frequently deleted element found in cytogenetic aberrations of acute myeloid malignancies.
|
14718661 |
2004 |
Constipation
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Cryptorchidism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Delayed ability to walk
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Delayed myelination
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Delayed speech and language development
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Developmental delay (disorder)
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
The four individuals with microdeletions encompassing KMT2E generally presented similarly to those with truncating variants, but the degree of developmental delay was greater.
|
31079897 |
2019 |
Downward slant of palpebral fissure
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Dysmorphic facies
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Epilepsy
|
0.100 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Feeding difficulties
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Full cheeks
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Generalized hypotonia
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|